PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0014544|epilepsy |
| Sentences | 10 |
| PubMedID- 24069608 | Once a consensus on the classification of psychotic syndromes associated with epilepsy is lacking, and neither dsm-iv nor icd-10 has addressed this issue specifically, the diagnosis of psychosis associated with mtle was established according to sachdev [29], meaning that patients with interictal psychosis did not experience the following: psychotic disorder temporally associated with seizures, changes in antiepileptic medications, epileptic status, delirium, and psychosis for paradoxical normalization. |
| PubMedID- 24350775 | After achieving a 2-year remission, 107 out of 442 children of their cohort (24,2%) experienced a relapse and the risk of relapse varied by epileptic syndrome, with juvenile myoclonic epilepsy carrying a very high risk and idiopathic partial epilepsy a very low risk. |
| PubMedID- 25889039 | Once a consensus on the classification of psychotic syndromes associated with epilepsy was lacking at the time of collection, and neither dsm-iv nor icd-10 has addressed this issue specifically (for a review, please see [20]), the diagnosis of psychosis associated with mtle was established according to sachdev [25], meaning that patients with interictal psychosis did not experience the following: psychotic disorder temporally associated with seizures, changes in antiepileptic medications, epileptic status, delirium, and psychosis for paradoxical normalization (for review, please see [26]). |
| PubMedID- 21365603 | The etiology is multifactorial, being affected by the type of epileptic syndrome, the cause of epilepsy, a high frequency of epileptic seizures, a previous history of status epilepticus, the age of onset of epilepsy, the antiepileptic treatment being selected, and the role of interictal epileptiform discharges. |
| PubMedID- 20509907 | Glut1 gene located in this region has recently appeared to cause a specific syndrome with drug-resistant epilepsy, developmental delay, microcephaly, spasticity, ataxia [5]. |
| PubMedID- 21685521 | According to our preliminary data vpa monotherapy increases the risk of metabolic syndrome in patients with epilepsy, but bmi did not differ between vpa monotherapy study group, cbz monotherapy study group and controls. |
| PubMedID- 23111748 | The etiology is multifactorial, being affected by the type of epileptic syndrome, the cause of epilepsy, the high frequency of epileptic seizures, a previous history of status epilepticus, the age at the onset of epilepsy, the antiepileptic treatment selected, and the role of interictal epileptiform discharges [1]. |
| PubMedID- 23755911 | Purpose: to evaluate the association between the bsmi polymorphism and vascular risk factors or metabolic syndrome in patients with epilepsy treated with valproate. |
| PubMedID- 25078464 | Background: no study has explored the risk of metabolic syndrome (ms) in patients with epilepsy treated with valproate (vpa) at the population level. |
| PubMedID- 25038132 | This retrospective cohort study aims to assess the distribution of seizure types and epileptic syndromes in children with epilepsy who were followed up in a tertiary outpatient pediatric neurology clinic between january 2004 and december 2009. |
Page: 1